Alembic Pharma has reported a profit after tax of Rs 153 crore for the quarter ended March 2023 compared to Rs 22 crore in the March quarter of 2022. Revenue from operations declined marginally to Rs 1406.45 crore in the quarter ended 31 March 2023 from Rs 1415.74 crore in the same quarter last year.
Subscribe To Our Free Newsletter |